BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32803128)

  • 1. Insights from mathematical modelling and quantitative analysis on the proposed WHO 2030 targets for visceral leishmaniasis on the Indian subcontinent.
    NTD Modelling Consortium Visceral Leishmaniasis Group
    Gates Open Res; 2019; 3():1651. PubMed ID: 32803128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models.
    Le Rutte EA; Coffeng LE; Bontje DM; Hasker EC; Postigo JA; Argaw D; Boelaert MC; De Vlas SJ
    Parasit Vectors; 2016 Jan; 9():24. PubMed ID: 26787302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.
    Kumar A; Singh VK; Tiwari R; Madhukar P; Rajneesh ; Kumar S; Gautam V; Engwerda C; Sundar S; Kumar R
    Front Immunol; 2023; 14():1236952. PubMed ID: 37638047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy Recommendations From Transmission Modeling for the Elimination of Visceral Leishmaniasis in the Indian Subcontinent.
    Le Rutte EA; Chapman LAC; Coffeng LE; Ruiz-Postigo JA; Olliaro PL; Adams ER; Hasker EC; Boelaert MC; Hollingsworth TD; Medley GF; de Vlas SJ
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S301-S308. PubMed ID: 29860292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of visceral leishmaniasis in the Indian subcontinent: a comparison of predictions from three transmission models.
    Le Rutte EA; Chapman LAC; Coffeng LE; Jervis S; Hasker EC; Dwivedi S; Karthick M; Das A; Mahapatra T; Chaudhuri I; Boelaert MC; Medley GF; Srikantiah S; Hollingsworth TD; de Vlas SJ
    Epidemics; 2017 Mar; 18():67-80. PubMed ID: 28279458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the Mathematical Modelling of Visceral Leishmaniasis.
    Rock KS; Quinnell RJ; Medley GF; Courtenay O
    Adv Parasitol; 2016; 94():49-131. PubMed ID: 27756459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential impact of human visceral leishmaniasis vaccines on population incidence.
    Le Rutte EA; Coffeng LE; Malvolti S; Kaye PM; de Vlas SJ
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008468. PubMed ID: 32614857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
    Chapman LAC; Spencer SEF; Pollington TM; Jewell CP; Mondal D; Alvar J; Hollingsworth TD; Cameron MM; Bern C; Medley GF
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25742-25750. PubMed ID: 32973088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.
    Hirve S; Boelaert M; Matlashewski G; Mondal D; Arana B; Kroeger A; Olliaro P
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004896. PubMed ID: 27490264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
    Hossain MS; Kumar A; Hossain AFMA; Mahshin M; Sharma A; Hossain MA; Sharma V; Haque R; Shamsuzzaman AKM; Maruf S; Ghosh P; Ahuja V; Mondal D
    Infect Dis Poverty; 2018 Aug; 7(1):80. PubMed ID: 30099967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uniting mathematics and biology for control of visceral leishmaniasis.
    Rock KS; le Rutte EA; de Vlas SJ; Adams ER; Medley GF; Hollingsworth TD
    Trends Parasitol; 2015 Jun; 31(6):251-9. PubMed ID: 25913079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a Sustainable Vector-Control Strategy in the Post Kala-Azar Elimination Era.
    Garlapati R; Iniguez E; Serafim TD; Mishra PK; Rooj B; Sinha B; Valenzuela JG; Srikantiah S; Bern C; Kamhawi S
    Front Cell Infect Microbiol; 2021; 11():641632. PubMed ID: 33768013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.
    Mondal D; Bern C; Ghosh D; Rashid M; Molina R; Chowdhury R; Nath R; Ghosh P; Chapman LAC; Alim A; Bilbe G; Alvar J
    Clin Infect Dis; 2019 Jul; 69(2):251-258. PubMed ID: 30357373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of vector characteristics of Phlebotomus argentipes in the kala-azar elimination programme in the Indian sub-continent.
    Chowdhury R; Kumar V; Mondal D; Das ML; Das P; Dash AP; Kroeger A
    Pathog Glob Health; 2016 May; 110(3):87-96. PubMed ID: 27376500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission.
    Le Rutte EA; Zijlstra EE; de Vlas SJ
    Trends Parasitol; 2019 Aug; 35(8):590-592. PubMed ID: 31266711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.
    Das VN; Pandey RN; Siddiqui NA; Chapman LA; Kumar V; Pandey K; Matlashewski G; Das P
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005196. PubMed ID: 27974858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India.
    Goyal V; Das VNR; Singh SN; Singh RS; Pandey K; Verma N; Hightower A; Rijal S; Das P; Alvar J; Bern C; Alves F
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008429. PubMed ID: 32687498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
    Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
    [No Abstract]   [Full Text] [Related]  

  • 19. Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.
    Sundar S; Singh OP; Chakravarty J
    Expert Rev Anti Infect Ther; 2018 Nov; 16(11):805-812. PubMed ID: 30289007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical modelling of the use of insecticide-treated nets for elimination of visceral leishmaniasis in Bihar, India.
    Fortunato AK; Glasser CP; Watson JA; Lu Y; Rychtář J; Taylor D
    R Soc Open Sci; 2021 Jun; 8(6):201960. PubMed ID: 34234949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.